0001104659-20-037930.txt : 20200324
0001104659-20-037930.hdr.sgml : 20200324
20200324213149
ACCESSION NUMBER: 0001104659-20-037930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200320
FILED AS OF DATE: 20200324
DATE AS OF CHANGE: 20200324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MICEK JOHN
CENTRAL INDEX KEY: 0001243187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36714
FILM NUMBER: 20739839
MAIL ADDRESS:
STREET 1: 300 HAMILTON AVENUE, 4TH FLOOR
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jaguar Health, Inc.
CENTRAL INDEX KEY: 0001585608
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 MISSION STREET, SUITE 2375
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-896-5081
MAIL ADDRESS:
STREET 1: 201 MISSION STREET, SUITE 2375
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: Jaguar Animal Health, Inc.
DATE OF NAME CHANGE: 20130830
4
1
a4.xml
4
X0306
4
2020-03-20
0
0001585608
Jaguar Health, Inc.
JAGX
0001243187
MICEK JOHN
C/O JAGUAR HEALTH INC.
201 MISSION STREET, SUITE 2375
SAN FRANCISCO
CA
94105
1
0
0
0
Stock Option (right to buy)
0.45
2020-03-20
4
A
0
26533
0
A
2030-03-20
Common Stock
26533
26533
D
Granted pursuant to the issuer's 2014 Stock Incentive Plan.
The option grant was approved by the issuer's board of directors on March 20, 2020.
The option will vest ratably on a monthly basis over 36 months from the grant date, so long as the director remains employed by the issuer.
/s/ Lisa A. Conte, Attorney-in-Fact
2020-03-24